1. Home
  2. SCNI vs FAMI Comparison

SCNI vs FAMI Comparison

Compare SCNI & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • FAMI
  • Stock Information
  • Founded
  • SCNI 2003
  • FAMI 2015
  • Country
  • SCNI Israel
  • FAMI China
  • Employees
  • SCNI N/A
  • FAMI N/A
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • FAMI Packaged Foods
  • Sector
  • SCNI Health Care
  • FAMI Consumer Staples
  • Exchange
  • SCNI Nasdaq
  • FAMI Nasdaq
  • Market Cap
  • SCNI 1.9M
  • FAMI 2.1M
  • IPO Year
  • SCNI N/A
  • FAMI 2018
  • Fundamental
  • Price
  • SCNI $2.91
  • FAMI $1.78
  • Analyst Decision
  • SCNI
  • FAMI
  • Analyst Count
  • SCNI 0
  • FAMI 0
  • Target Price
  • SCNI N/A
  • FAMI N/A
  • AVG Volume (30 Days)
  • SCNI 15.6K
  • FAMI 137.6K
  • Earning Date
  • SCNI 05-07-2025
  • FAMI 05-27-2025
  • Dividend Yield
  • SCNI N/A
  • FAMI N/A
  • EPS Growth
  • SCNI N/A
  • FAMI N/A
  • EPS
  • SCNI N/A
  • FAMI N/A
  • Revenue
  • SCNI $658,000.00
  • FAMI $64,131,332.00
  • Revenue This Year
  • SCNI N/A
  • FAMI N/A
  • Revenue Next Year
  • SCNI N/A
  • FAMI N/A
  • P/E Ratio
  • SCNI N/A
  • FAMI N/A
  • Revenue Growth
  • SCNI N/A
  • FAMI N/A
  • 52 Week Low
  • SCNI $1.90
  • FAMI $1.43
  • 52 Week High
  • SCNI $8.92
  • FAMI $11.28
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 60.01
  • FAMI 50.56
  • Support Level
  • SCNI $2.66
  • FAMI $1.62
  • Resistance Level
  • SCNI $2.96
  • FAMI $2.22
  • Average True Range (ATR)
  • SCNI 0.18
  • FAMI 0.18
  • MACD
  • SCNI 0.04
  • FAMI 0.03
  • Stochastic Oscillator
  • SCNI 93.15
  • FAMI 29.03

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

Share on Social Networks: